Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted EPS (Basic) of -$1.98 for Q3 2025, down 26.8% on a QoQ basis from -$1.56 in Q2 2025, and down 50.05% year-over-year from -$3.97 in Q3 2024.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings has reported EPS (Basic) for 13 years, with the latest figure at -$1.98 in Q3 2025.
- On a quarterly basis, EPS (Basic) fell 50.05% year-over-year to -$1.98 in Q3 2025; TTM through Sep 2025 was -$6.17, a 51.25% decrease from a year earlier, with the FY2024 full-year figure at -$4.64, up 59.01% from the prior year.
- EPS (Basic) was -$1.98 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from -$1.56 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.07 in Q3 2022, with the low at -$4.14 in Q1 2023.
- Average EPS (Basic) over 5 years is -$1.29, with a median of -$1.26 recorded in 2024.
- The sharpest annual moves came in 2021 and 2023: EPS (Basic) soared 73.29% in 2021, then sank 5982.65% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.08 in 2021, then tumbled by 3084.42% to -$2.59 in 2022, then climbed by 1.51% to -$2.55 in 2023, then surged by 54.71% to -$1.15 in 2024, then slumped by 71.8% to -$1.98 in 2025.
- The last three EPS (Basic) figures came in at -$1.98 (Q3 2025), -$1.56 (Q2 2025), and -$1.62 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.98 |
| Jun 30, 2025 | -1.56 |
| Mar 31, 2025 | -1.62 |
| Dec 31, 2024 | -1.15 |
| Sep 30, 2024 | -1.32 |
| Jun 30, 2024 | -1.05 |
| Mar 31, 2024 | -1.26 |
| Dec 31, 2023 | -2.55 |
| Sep 30, 2023 | -2.37 |
| Jun 30, 2023 | -2.15 |
| Mar 31, 2023 | -4.14 |
| Dec 31, 2022 | -2.59 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.08 |
| Sep 30, 2021 | -0.11 |
| Jun 30, 2021 | -0.14 |
| Mar 31, 2021 | -0.13 |
| Dec 31, 2020 | -0.27 |